What's breaking now, across thousands of outlets.
Researchers at Arizona State University, U.S., have found that a high-fat diet leaves lasting changes in intestinal stem cells, potentially increasing the risk of tumor development.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
Open enrollment can bring unexpected challenges for seniors.
Open enrollment can bring unexpected challenges for seniors.
With a standardized cell naming system and infrastructure for data collection and analysis, the basal ganglia project sets the stage for a whole-brain primate atlas.
Robert Plenge is leaving as part of a shift that will see the company merge together its R&D department in a bid to speed development and capitalize on new technologies.
Plus, news about Vor Bio, RemeGen, Merck KGaA, Aidea, Astellas and Immuneering. BioNTech acquires PRV for $205 million: The German biotech scooped up the FDA voucher from Scholar Rock, with plans ...
